U.S. Food and Drug Administration’s Arthritis Advisory Committee Confirms Date to Review XIAFLEX(TM) for the Treatment … (Marketwire)

MALVERN, PA--(Marketwire - July 31, 2009) - Auxilium Pharmaceuticals, Inc. ( NASDAQ : AUXL ), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration's (FDA) Arthritis Advisory Committee confirmed it will review XIAFLEXT during an advisory committee hearing at the Holiday Inn in Gaithersburg, MD on September 16, 2009. The Arthritis Advisory Committee is ...

[News Source]


   Posted in Fentanyl